Variant report

Variant	nsv550819
Chromosome Location	chr10:50815512-50835264
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:316)
CpG islands
(count:2320)
Chromatin interactive
region (count:21)
LncRNA
region (count:3)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:316 , 50 per page) page: 1 2 3 4 5 6 7

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr10:50818924-50819042	H1-hESC	embryonic stem cell:	n/a	n/a
2	BACH1	chr10:50819285-50819539	H1-hESC	embryonic stem cell:	n/a	n/a
3	BACH1	chr10:50818288-50818355	H1-hESC	embryonic stem cell:	n/a	n/a
4	BACH1	chr10:50821165-50821429	H1-hESC	embryonic stem cell:	n/a	n/a
5	BACH1	chr10:50827761-50827855	H1-hESC	embryonic stem cell:	n/a	n/a
6	CEBPB	chr10:50816441-50816632	H1-hESC	embryonic stem cell:	n/a	n/a
7	CEBPB	chr10:50816413-50816417	K562	blood:	n/a	n/a
8	CHD2	chr10:50822705-50822712	H1-hESC	embryonic stem cell:	n/a	n/a
9	CHD2	chr10:50819575-50819775	H1-hESC	embryonic stem cell:	n/a	n/a
10	CHD2	chr10:50817612-50817790	H1-hESC	embryonic stem cell:	n/a	n/a
11	CTBP2	chr10:50816892-50818054	H1-hESC	embryonic stem cell:	n/a	n/a
12	CTBP2	chr10:50819126-50822240	H1-hESC	embryonic stem cell:	n/a	n/a
13	CTCF	chr10:50827781-50828016	H1-hESC	embryonic stem cell:	n/a	n/a
14	CTCF	chr10:50827780-50827930	BJ	skin:	n/a	n/a
15	CTCF	chr10:50824700-50824850	GM12875	blood:	n/a	chr10:50824759-50824772 chr10:50824752-50824773 chr10:50824757-50824775
16	CTCF	chr10:50827780-50827930	GM12864	blood:	n/a	n/a
17	CTCF	chr10:50827840-50827990	HFF-Myc	foreskin:	n/a	n/a
18	CTCF	chr10:50827860-50828010	GM12875	blood:	n/a	n/a
19	CTCF	chr10:50824565-50824857	H1-hESC	embryonic stem cell:	n/a	chr10:50824759-50824772 chr10:50824752-50824773 chr10:50824757-50824775
20	CTCF	chr10:50827840-50827990	GM12875	blood:	n/a	n/a
21	CTCF	chr10:50827860-50828010	GM12868	blood:	n/a	n/a
22	CTCF	chr10:50819725-50819917	H1-hESC	embryonic stem cell:	n/a	n/a
23	CTCF	chr10:50824720-50824870	GM12871	blood:	n/a	chr10:50824759-50824772 chr10:50824752-50824773 chr10:50824757-50824775
24	CTCF	chr10:50827840-50827990	GM12873	blood:	n/a	n/a
25	CTCF	chr10:50824700-50824850	GM12872	blood:	n/a	chr10:50824759-50824772 chr10:50824752-50824773 chr10:50824757-50824775
26	CTCF	chr10:50827800-50827950	HEEpiC	esophagus:	n/a	n/a
27	CTCF	chr10:50824640-50824790	Caco-2	colon:	n/a	chr10:50824759-50824772 chr10:50824752-50824773 chr10:50824757-50824775
28	CTCF	chr10:50827900-50828050	GM12873	blood:	n/a	n/a
29	CTCF	chr10:50824687-50824838	GM12891	blood:	n/a	chr10:50824759-50824772 chr10:50824752-50824773 chr10:50824757-50824775
30	CTCF	chr10:50827734-50828047	K562	blood:	n/a	n/a
31	CTCF	chr10:50820960-50821110	HMEC	breast:	n/a	n/a
32	CTCF	chr10:50827820-50827970	Caco-2	colon:	n/a	n/a
33	CTCF	chr10:50825097-50825171	MCF-7	breast:	n/a	n/a
34	CTCF	chr10:50827780-50827930	GM12869	blood:	n/a	n/a
35	CTCF	chr10:50824700-50824850	Hela-S3	cervix:	n/a	chr10:50824759-50824772 chr10:50824752-50824773 chr10:50824757-50824775
36	CTCF	chr10:50827820-50827970	HEK293	kidney:	n/a	n/a
37	CTCF	chr10:50824783-50824807	GM10266	blood:	n/a	n/a
38	CTCF	chr10:50820960-50821110	HBMEC	blood vessel:	n/a	n/a
39	CTCF	chr10:50827080-50827230	SK-N-SH_RA	brain:	n/a	n/a
40	CTCF	chr10:50827140-50827290	NB4	blood:	n/a	chr10:50827224-50827245 chr10:50827231-50827244 chr10:50827229-50827247 chr10:50827230-50827246
41	CTCF	chr10:50827860-50828010	K562	blood:	n/a	n/a
42	CTCF	chr10:50820920-50821070	HepG2	liver:	n/a	n/a
43	CTCF	chr10:50824620-50824770	GM12866	blood:	n/a	n/a
44	CTCF	chr10:50827840-50827990	GM06990	blood:	n/a	n/a
45	CTCF	chr10:50827740-50827890	HAc	cerebellar:	n/a	n/a
46	CTCF	chr10:50820913-50821168	K562	blood:	n/a	n/a
47	CTCF	chr10:50824620-50824770	Caco-2	colon:	n/a	n/a
48	CTCF	chr10:50824718-50824816	GM13977	blood:	n/a	chr10:50824759-50824772 chr10:50824752-50824773 chr10:50824757-50824775
49	CTCF	chr10:50824694-50824860	MCF-7	breast:	n/a	chr10:50824759-50824772 chr10:50824752-50824773 chr10:50824757-50824775
50	CTCF	chr10:50827847-50827977	HepG2	liver:	n/a	n/a

(count:2320 , 50 per page) page: 1 2 3 4 5 6 7 ... 47

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr10:50826395-50826445	HRCEpiC	kidney:	n/a
2	chr10:50816262-50816312	HAEpiC	amniotic membrane:	n/a
3	chr10:50826395-50826445	HRCEpiC	kidney:	n/a
4	chr10:50816262-50816312	HAEpiC	amniotic membrane:	n/a
5	chr10:50821053-50821103	HCM	heart:	n/a
6	chr10:50820604-50820654	GM12878	blood:	n/a
7	chr10:50821053-50821103	HCF	heart:	n/a
8	chr10:50821597-50821647	Caco-2	colon:	n/a
9	chr10:50816262-50816312	HRPEpiC	eye:	n/a
10	chr10:50816262-50816312	Caco-2	colon:	n/a
11	chr10:50822175-50822225	AG09319	gingival:	n/a
12	chr10:50816262-50816312	SAEC	small airway:	n/a
13	chr10:50821093-50821143	HUVEC	blood vessel:	n/a
14	chr10:50821597-50821647	HEK293	kidney:	embryo
15	chr10:50817104-50817154	GM19239	blood:	n/a
16	chr10:50821031-50821081	ECC-1	luminal epithelium:	n/a
17	chr10:50821093-50821143	GM12891	blood:	n/a
18	chr10:50817213-50817263	Hela-S3	cervix:	n/a
19	chr10:50817306-50817356	GM12892	blood:	n/a
20	chr10:50816917-50816967	SAEC	small airway:	n/a
21	chr10:50820604-50820654	ECC-1	luminal epithelium:	n/a
22	chr10:50821597-50821647	NH-A	brain:	n/a
23	chr10:50817096-50817146	HEEpiC	esophagus:	n/a
24	chr10:50818299-50818349	HPAEpiC	pulmonary alveolar:	n/a
25	chr10:50821031-50821081	HepG2	liver:	n/a
26	chr10:50829959-50830009	HCPEpiC	choroid plexus:	n/a
27	chr10:50816262-50816312	SK-N-SH	brain:	n/a
28	chr10:50817306-50817356	HCF	heart:	n/a
29	chr10:50816262-50816312	GM12892	blood:	n/a
30	chr10:50817096-50817146	SK-N-SH_RA	brain:	n/a
31	chr10:50817810-50817860	HNPCEpiC	eye:	n/a
32	chr10:50821031-50821081	HCPEpiC	choroid plexus:	n/a
33	chr10:50818707-50818757	AG04450	lung:	fetal
34	chr10:50821989-50822039	CMK	blood:	n/a
35	chr10:50816262-50816312	HepG2	liver:	n/a
36	chr10:50824106-50824156	MCF10A-Er-Src	breast:	n/a
37	chr10:50817804-50817854	GM12891	blood:	n/a
38	chr10:50820803-50820853	K562	blood:	n/a
39	chr10:50824106-50824156	Hela-S3	cervix:	n/a
40	chr10:50818652-50818702	HRPEpiC	eye:	n/a
41	chr10:50821989-50822039	HCF	heart:	n/a
42	chr10:50822606-50822656	Hepatocyte	liver:	n/a
43	chr10:50817306-50817356	ovcar-3	ovarian:	n/a
44	chr10:50821161-50821211	HEK293	kidney:	embryo
45	chr10:50818911-50818961	HNPCEpiC	eye:	n/a
46	chr10:50817104-50817154	HNPCEpiC	eye:	n/a
47	chr10:50818911-50818961	BE2_C	brain:	n/a
48	chr10:50821093-50821143	HMEC	breast:	n/a
49	chr10:50820278-50820328	AG04450	lung:	fetal
50	chr10:50821161-50821211	HEEpiC	esophagus:	n/a

(count:21 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr10:50820607..50822869-chr10:50825214..50827220,2	MCF-7	breast:
2	chr10:50817979..50819560-chr10:50821869..50824788,2	K562	blood:
3	chr10:50835151..50837782-chr10:50840451..50842242,2	K562	blood:
4	chr10:50828397..50830202-chr10:50831455..50833344,2	K562	blood:
5	chr10:50817275..50819669-chr10:50821869..50826020,4	K562	blood:
6	chr10:50815088..50816772-chr10:50825663..50828109,2	K562	blood:
7	chr10:50828397..50830202-chr10:50831455..50833344,2	K562	blood:
8	chr10:50833978..50837174-chr10:50837215..50839127,3	K562	blood:
9	chr10:50817275..50819669-chr10:50821869..50826020,4	K562	blood:
10	chr10:50829978..50831621-chr10:50840399..50842582,2	MCF-7	breast:
11	chr10:50814065..50816075-chr10:50831042..50833228,2	K562	blood:
12	chr10:50814760..50816913-chr10:50829962..50832640,2	MCF-7	breast:
13	chr10:50814760..50816913-chr10:50829962..50832640,2	MCF-7	breast:
14	chr10:50813090..50816091-chr10:50817397..50820029,4	K562	blood:
15	chr10:50817979..50819560-chr10:50821869..50824788,2	K562	blood:
16	chr10:50829861..50831911-chr10:50834667..50836429,2	MCF-7	breast:
17	chr10:50815088..50816772-chr10:50825663..50828109,2	K562	blood:
18	chr10:50829861..50831911-chr10:50834667..50836429,2	MCF-7	breast:
19	chr10:50814065..50816075-chr10:50831042..50833228,2	K562	blood:
20	chr10:50801243..50801878-chr10:50826995..50827951,3	K562	blood:
21	chr10:50825488..50827089-chr10:50860500..50862659,2	MCF-7	breast:

(count:3 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-SLC18A3-1	chr10:50824548-50824648	NONHSAT013316
2	lnc-SLC18A3-1	chr10:50821165-50821248	NONHSAT013316
3	lnc-SLC18A3-1	chr10:50827771-50827841	NONHSAT013316

No data

Variant related genes	Relation type
CHAT	TF binding region
SLC18A3	TF binding region
CHAT	CpG island
SLC18A3	CpG island
ENSG00000187714	chromatin interactions
ENSG00000070748	chromatin interactions

Extended variants
information (count: 945 )
Associated
traits (count: 74 )

Variant overlapped rSNPs/rCNVs (count:945 , 50 per page) page: 1 2 3 4 5 6 7 ... 19

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs885834	chr10:50815512-50815513	Bivalent Enhancer Bivalent/Poised TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs552040974	chr10:50815548-50815549	Bivalent Enhancer Bivalent/Poised TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
3	rs189407135	chr10:50815593-50815594	Bivalent Enhancer Bivalent/Poised TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
4	rs530984643	chr10:50815632-50815633	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
5	rs549097585	chr10:50815640-50815641	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
6	rs138060127	chr10:50815656-50815657	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
7	rs79634917	chr10:50815690-50815691	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
8	rs546638760	chr10:50815692-50815693	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
9	rs7067651	chr10:50815696-50815697	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers	TF binding region Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
10	rs557199136	chr10:50815749-50815750	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
11	rs560716063	chr10:50815767-50815768	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
12	rs3810946	chr10:50815803-50815804	Bivalent/Poised TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
13	rs529818987	chr10:50815856-50815857	Bivalent/Poised TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
14	rs552223928	chr10:50815860-50815861	Bivalent/Poised TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
15	rs75287762	chr10:50815871-50815872	Bivalent/Poised TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
16	rs572929695	chr10:50815881-50815882	Bivalent/Poised TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
17	rs540240079	chr10:50815892-50815893	Bivalent/Poised TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
18	rs534585378	chr10:50815904-50815905	Bivalent/Poised TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
19	rs554735434	chr10:50815913-50815914	Bivalent/Poised TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
20	rs564766364	chr10:50815942-50815943	Bivalent/Poised TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
21	rs180699336	chr10:50815951-50815952	Bivalent/Poised TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
22	rs149508472	chr10:50815983-50815984	Bivalent/Poised TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
23	rs563991835	chr10:50816042-50816043	Bivalent/Poised TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
24	rs75772065	chr10:50816112-50816113	Bivalent/Poised TSS Bivalent Enhancer Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
25	rs78167513	chr10:50816120-50816121	Bivalent/Poised TSS Bivalent Enhancer Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
26	rs561057886	chr10:50816149-50816150	Bivalent/Poised TSS Bivalent Enhancer Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
27	rs528604533	chr10:50816189-50816190	Bivalent/Poised TSS Bivalent Enhancer Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
28	rs547068507	chr10:50816197-50816198	Bivalent/Poised TSS Bivalent Enhancer Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
29	rs143993213	chr10:50816208-50816209	Bivalent/Poised TSS Bivalent Enhancer Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
30	rs532525769	chr10:50816218-50816219	Bivalent/Poised TSS Bivalent Enhancer Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
31	rs376990197	chr10:50816255-50816256	Bivalent/Poised TSS Bivalent Enhancer Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
32	rs550618874	chr10:50816262-50816263	Bivalent/Poised TSS Bivalent Enhancer Weak transcription	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
33	rs569147594	chr10:50816286-50816287	Bivalent/Poised TSS Bivalent Enhancer Weak transcription	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
34	rs116127099	chr10:50816298-50816299	Bivalent/Poised TSS Bivalent Enhancer Weak transcription	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
35	rs368267877	chr10:50816299-50816300	Bivalent/Poised TSS Bivalent Enhancer Weak transcription	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
36	rs554762186	chr10:50816318-50816319	Bivalent/Poised TSS Bivalent Enhancer Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
37	rs73319003	chr10:50816325-50816326	Bivalent/Poised TSS Bivalent Enhancer Weak transcription	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
38	rs368776622	chr10:50816341-50816342	Bivalent/Poised TSS Bivalent Enhancer Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
39	rs556680573	chr10:50816388-50816389	Bivalent/Poised TSS Bivalent Enhancer Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
40	rs115663640	chr10:50816414-50816415	Bivalent Enhancer Bivalent/Poised TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
41	rs139621339	chr10:50816418-50816419	Bivalent Enhancer Bivalent/Poised TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
42	rs371232226	chr10:50816428-50816429	Bivalent Enhancer Bivalent/Poised TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
43	rs557390527	chr10:50816433-50816434	Bivalent Enhancer Bivalent/Poised TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
44	rs575484538	chr10:50816454-50816455	Bivalent Enhancer Bivalent/Poised TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
45	rs542905402	chr10:50816472-50816473	Bivalent Enhancer Bivalent/Poised TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
46	rs371609620	chr10:50816474-50816475	Bivalent Enhancer Bivalent/Poised TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
47	rs142830955	chr10:50816503-50816504	Bivalent Enhancer Bivalent/Poised TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
48	rs576683835	chr10:50816509-50816510	Bivalent Enhancer Bivalent/Poised TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
49	rs528640728	chr10:50816515-50816516	Bivalent Enhancer Bivalent/Poised TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
50	rs540406467	chr10:50816556-50816557	Bivalent Enhancer Bivalent/Poised TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:74)

Disease	PMID	Source
Pancreatic endocrine tumor	17639061	CNVD
Gastric cancer	17908304	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Melanoma	18172304	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Ewing''s sarcoma	17952124	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Acute lymphoblastic leukemia	20724749	CNVD
Autism	22495311	CNVD
Esophageal cancer	21851588	CNVD
Prostate cancer	18632612	CNVD
Autism	18414403	CNVD
Cockayne syndrome	18421352	CNVD
Glioblastoma	16823260	CNVD
Medulloblastoma	16968546	CNVD
Neuroblastoma	17533364	CNVD
Cancer	21183584	CNVD
T-cell lymphomas	19863542	CNVD
Testicular germ cell tumor	18059402	CNVD
Squamous cell cancer	21044232	CNVD
Glioma	21971842	CNVD
Cancer	21637783	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Papillary thyroid carcinoma	21436994	CNVD
Hirschsprung''s Disease	21712996	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Obesity	21956041	CNVD
Renal cell carcinoma	18765545	CNVD
Developmental delay	21948486	CNVD
Dysmorphic features	21948486	CNVD
Epilepsy	21948486	CNVD
Breast cancer	21785460	CNVD
Intellectual disability	21948486	CNVD
Schizophrenia	23813976	CNVD
Intellectual disability	22045946	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Autism	21948486	CNVD
cleft palate	21948486	CNVD
Encephalopathy	21948486	CNVD
Lung cancer	18438408	CNVD
Autism	22543975	CNVD
Breast cancer	21364760	CNVD
small cell lung cancer	20016488	CNVD
skeletal anomalies	21948486	CNVD
speech delay	21948486	CNVD
Colorectal cancer	16272173	CNVD
Breast cancer	21990379	CNVD
Myelofibrosis	22110671	CNVD
Metanephric adenoma	20802469	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Breast cancer	22522925	CNVD
XY gonadal dysgenesis	20685758	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:511 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr10:50813200-50815600	Enhancers	Cortex derived primary cultured neurospheres	brain
2	chr10:50814800-50815600	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
3	chr10:50815000-50815600	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
4	chr10:50815200-50815600	Bivalent Enhancer	H1 Derived Mesenchymal Stem Cells	ES cell derived
5	chr10:50815200-50815600	Bivalent Enhancer	iPS DF 6.9 Cell Line	embryonic stem cell
6	chr10:50815200-50815600	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
7	chr10:50815200-50815600	Bivalent Enhancer	Brain Inferior Temporal Lobe	brain
8	chr10:50815200-50815600	Bivalent Enhancer	Left Ventricle	heart
9	chr10:50815200-50815600	Enhancers	Pancreas	Pancrea
10	chr10:50815200-50815600	Enhancers	Dnd41	blood
11	chr10:50815200-50815800	Bivalent Enhancer	Primary Natural Killer cells fromperipheralblood	blood
12	chr10:50815200-50815800	Bivalent Enhancer	Fetal Muscle Trunk	muscle
13	chr10:50815200-50815800	Bivalent Enhancer	Placenta	Placenta
14	chr10:50815200-50815800	Bivalent Enhancer	Fetal Stomach	stomach
15	chr10:50815200-50816800	Bivalent Enhancer	iPS DF 19.11 Cell Line	embryonic stem cell
16	chr10:50815200-50816800	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
17	chr10:50815200-50818000	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
18	chr10:50815400-50815600	Bivalent Enhancer	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
19	chr10:50815400-50815600	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
20	chr10:50815400-50815600	Bivalent Enhancer	Primary hematopoietic stem cells short term culture	blood
21	chr10:50815400-50815600	Bivalent Enhancer	Brain Dorsolateral Prefrontal Cortex	brain
22	chr10:50815400-50815600	Bivalent Enhancer	Esophagus	oesophagus
23	chr10:50815400-50815600	Enhancers	Gastric	stomach
24	chr10:50815400-50815800	Bivalent Enhancer	Brain Hippocampus Middle	brain
25	chr10:50815400-50815800	Enhancers	Spleen	Spleen
26	chr10:50815600-50815800	Bivalent Enhancer	Ganglion Eminence derived primary cultured neurospheres	brain
27	chr10:50815600-50817000	Weak transcription	Pancreas	Pancrea
28	chr10:50815600-50817400	Bivalent Enhancer	Cortex derived primary cultured neurospheres	brain
29	chr10:50815800-50817000	Weak transcription	Gastric	stomach
30	chr10:50816400-50816800	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
31	chr10:50816600-50816800	Bivalent Enhancer	HUES6 Cell Line	embryonic stem cell
32	chr10:50816600-50817000	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
33	chr10:50816600-50817000	Bivalent Enhancer	iPS DF 6.9 Cell Line	embryonic stem cell
34	chr10:50816600-50817200	Enhancers	Placenta Amnion	Placenta Amnion
35	chr10:50816600-50820000	Bivalent/Poised TSS	H9 Cell Line	embryonic stem cell
36	chr10:50816600-50820000	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
37	chr10:50816800-50817000	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
38	chr10:50816800-50817200	Bivalent Enhancer	Fetal Stomach	stomach
39	chr10:50816800-50817400	Flanking Bivalent TSS/Enh	H1 Cell Line	embryonic stem cell
40	chr10:50816800-50817400	Bivalent Enhancer	H9 Derived Neuron Cultured Cells	ES cell derived
41	chr10:50816800-50817400	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
42	chr10:50816800-50817400	Flanking Bivalent TSS/Enh	ES-UCSF4 Cell Line	embryonic stem cell
43	chr10:50816800-50817600	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin03	Skin
44	chr10:50816800-50817600	Bivalent Enhancer	Placenta	Placenta
45	chr10:50816800-50817800	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
46	chr10:50816800-50818000	Flanking Bivalent TSS/Enh	iPS DF 19.11 Cell Line	embryonic stem cell
47	chr10:50816800-50819400	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
48	chr10:50816800-50819800	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
49	chr10:50817000-50817200	Bivalent Enhancer	ES-WA7 Cell Line	embryonic stem cell
50	chr10:50817000-50817200	Flanking Bivalent TSS/Enh	HUES48 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links